Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Piramal Pharma to Expand its Aurora Facility in Canada
Piramal Pharma Solutions business is investing US$188 million for the expansion of its Aurora facility in Canada
World's Largest CMDO to be Built in Pennsylvania
The Discovery Labs in association with Deerfield Management Company is building The Center for Breakthrough Medicines, the worlds largest Cell and Gene Therapy Contract Development and Manufacturing Organization CDMO at an investment of US$11 billion in Pennsylvania
Eli Lilly to Invest US$470million for Pharmaceutical Plant Construction
Eli Lilly and Company will invest US$470 million for the construction of a new stateoftheart pharmaceutical manufacturing facility in North Carolinas Research Triangle Park
GE Healthcare Life Sciences to Build New Manufacturing Facility in Switzerland
GE Healthcare Life Sciences is building a new manufacturing facility, in the new Signy Park, in Grens, Switzerland The main focus of the 7,360 square meter facility will be the manufacture of singleuse kits for the Sepax and Sefia cell processing systems
PCI Pharma Services Starts Expansion of its Tredegar Facility in UK
PCI Pharma Services has begun an expansion project with an investment of US$12 million at its Tredegar facility in Wales, UK
FUJIFILM Diosynth Biotechnologies Invests US$55 million for Gene Therapy Facility Expansion
FUJIFILM Diosynth Biotechnologies FDB has announced an investment of US$55million to establish a new Gene Therapy Innovation Center
Medpharma Expands its Center of Excellence Facility in North Carolina
Medpharma has completed a major expansion project of its US Center of Excellence at an investment of US$4million in Durham, North Carolina
Thermo Fisher Scientific Expands its Viral Vectors Facility in US
Thermo Fisher Scientific has unveiled the US$6million expansion of its gene therapy and viral vector services site in Alachua, Florida The expansion is part of the companys US$270 million investment to expand its capabilities and capacity to support its customers
Rentschler Biopharma Starts Bioreactor Facility in US
Rentschler Biopharma has started operations of its new facility, a singleuse bioreactor in Milford, MA, in the Greater Boston area The 93,000 square foot XDR500 bioreactor with a working volume of 100500L and downstream process capabilities of 28gL, is part of the stateoftheart GMP facility suite concept
Frontage Laboratories Expands Bioanalytical Capacity and Capabilities
Frontage Laboratories is expanding its bioanalytical laboratories in the US, in Exton, PA The expansion will include an additional 10,000 square feet of laboratory space to support biologic drug development, cell and gene therapy development as well as biomarker analysis
